Condition (MeSH)
Penetrating Atherosclerotic Ulcer
ClinicalTrials.gov lists 23 trials for Penetrating Atherosclerotic Ulcer or a narrower condition beneath it. Bolton Medical has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Penetrating Atherosclerotic Ulcer itself; the rest are tagged with a narrower condition beneath it.
When did Penetrating Atherosclerotic Ulcer trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 1 |
| 2022 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2014 | 2 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Penetrating Atherosclerotic Ulcer trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 12 |
| Observational | 9 |
| Expanded access | 2 |
How many Penetrating Atherosclerotic Ulcer trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Completed | 5 |
| Approved for marketing | 2 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Penetrating Atherosclerotic Ulcer trials? (10)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bolton Medical | 3 |
| Cook Research Incorporated | 2 |
| Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd | 2 |
| Vascutek Ltd. | 2 |
| W.L.Gore & Associates | 2 |
Showing 5 of 10 sponsors.
Which serious adverse events do Penetrating Atherosclerotic Ulcer trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Bleeding events | 45 | 1 |
| Pulmonary Complications | 40 | 1 |
| Vascular | 40 | 1 |
| Cardiac complications | 33 | 1 |
| Neurological complications | 27 | 1 |
Showing 5 of 10 adverse events.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: drugs tested, publications, prevalence, rare-disease identity, and sub-conditions in mesh.